Forbes March 8, 2024
Joshua Cohen

Like last year, healthcare featured prominently in President Biden’s State of the Union Address. But unlike in 2023, this speech was different in tone on many topics, including healthcare. In an impassioned address, Biden took on the pharmaceutical industry. Asserting that Americans “pay more for prescription drugs than any nation in the world” he declared it time to enable the federal government to negotiate the prices of more prescription drugs and to broaden the reach to part of the commercial sector of health insurance. “They’re making a lot of money, guys,” Biden said of drug companies. And he added that after drug prices are lowered “they’ll still be extremely profitable.”

Healthcare has been a staple in many State of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
Trump tariffs could drive up generic drug costs: 5 takeaways
Senators urge Congress to avert Medicare physician pay cut

Share This Article